Skip to main content
. 2019 May 10;29:1–6. doi: 10.1016/j.gore.2019.05.002

Fig. 1.

Fig. 1

Cumulative probability of progression free survival at two years was 51%. A. Progression free survival of study population. B. Progression free survival by salvage therapy cohort. The multimodality cohort had increased progression free survival compared to non-surgery or surgery cohorts.